1 / 28

Opioid Induced Hyperalgesia

Opioid Induced Hyperalgesia. Walter Ling MD Integrated Substance Abuse Programs UCLA lwalter@ucla.edu APA annual meeting New York NY May 3, 2004. Opioid Induced Hyperalgesia. Hyperalgesia: Exaggerated response to noxious stimuli Allodynia: Normally innocuous stimuli produce pain.

mallorie
Télécharger la présentation

Opioid Induced Hyperalgesia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opioid Induced Hyperalgesia Walter Ling MD Integrated Substance Abuse Programs UCLA lwalter@ucla.edu APA annual meeting New York NY May 3, 2004

  2. Opioid Induced Hyperalgesia • Hyperalgesia: Exaggerated response to noxious stimuli • Allodynia: Normally innocuous stimuli produce pain

  3. Hyperalgesia: Why Bother? • Common among patients • More patients taking opioids • Chronic pain &/or opioid addiction • Opioid prescription use and abuse • Universal to opioid use • Confuses clinical picture • Complicates pain management

  4. Chronic Opioid Exposure • Tolerance • Dependence • Abstinence • Addiction • Hyperalgesia

  5. Hyperalgesia • Opioid administration, in particular chronic administration, induced hyperalgesia & tolerance • Related but distinct from tolerance • Sensitization vs desensitization • Shared mechanism with chronic, neuropathic pain • Confusing pain assessment and management

  6. Factors reducing opioid analgesia • Loss of opioid receptors • Disrupted synergy between supra-spinal and spinal opioid systems • Anti-opioid peptides • Non-opioid mechanisms (NMDA) • Tolerance • A beta-fiber-mediated allodynia • Opioid induced hyperalgesia

  7. Tolerance &hyperalgesia:common mechanisms

  8. NMDA Receptor Activation from Persistent Pain & Opioid Administration: I • Ca+ + influx • PKC mediated phosphorylation • NMDA receptor • Mu opioid receptor • NO & superoxides • Dark neurons • Dynorphine A release • Release of nociceptive neurotransmitters • Glutamate, substance P, CGRP

  9. NMDA Receptor Activation from Persistent Pain & Opioid Administration: II • Production of anti-opioids • Vasopressin, oxytocin, nociceptin, NPFF, CCK • Mu receptor desensitization • G protein coupled receptor kinases •  arrestin,  adrenergic receptor kinases •  receptor agonists • / opioid receptor complexes

  10. Methadone maintenance patients: pain sensitivity (CPT)

  11. Morphine in MM patients

  12. HIGH DOSE MORPHINE: CP TEST

  13. RESPONSE BY STIMULUS INTENSITY Hyperalgesia: methadone maintenance Hyperalgesia/ Allodynia Controls Pain Tolerance Response Pain Threshold Stimulus Intensity

  14. Opponent Process Theory Opioid-induced hyperalgesia Pain tolerance Opioid-induced analgesia

  15. OIH vs Pre-existing Pain • Increase in pain intensity with further opioid administration • Decrease in pain threshold/tolerance • Changing slope between threshold and tolerance ? • Diffused pain extending beyond distribution of pre-existing pain • Presence of allodynia?

  16. Lots of Unknown • More research on hyperalgesia: • What opioids make a difference, if any? • Route and manner of administration matter? • How much and for how long? • Can we separate hyperalgesia from tolerance? • Can we prevent or reverse hyperalgesia? • NMDA receptor antagonists • NK1 antagonists • Opioids of different receptor mechanisms • Combining with ultra low dose antagonists

  17. Morphia: Hyperalgesia & allodynia • If any man want to learn sympathetic charity, let him keep pain subdued for six months by morphia, and then make the experiment of giving up the drug. By this time he will have become irritable, nervous and cowardly. The nerves, muffled, so to speak, by narcotics, will have grown to be not less sensitive, butacutely, abnormally capable of feeling pain and of feeling as pain a multitude of things not usually competent to cause it.S.W. Mitchell

  18. Overcoming OIH “Turning off” hyperalgesia • PKC inhibitors: gangliosides • NMDA Antagonists • NOS inhibitors • Calcium channel antagonists • Orphanin/FQ (nociceptin) receptor modulators • NK antagonists • Dynorphin modulators • Ultra-low dose antagonists

  19. Overcoming Opioid Tolerance & Hyperalgesia: Promising Examples • NMDA receptor antagonists • Opioids with novel receptor mechanisms • Combining opioid agonists with ultra low dose antagonists • Morphine /naltrexone • Buprenorphine/ORL antagonist

  20. NMDA receptor antagonist: ketamine

  21. Agonists acting on different receptor mechanisms: oxycodone & morphine antinocoception after selective mu antagonist naloxonazine administration

  22. Co-administration of ultra low dose NTX with morphine

  23. Clinical Implications • Analogy with TD? • Ultra-rapid detoxification?

  24. Detoxification Detoxification is good for a lot of things; staying off drugs is not one of them.

  25. Thanks to National Institute on Drug Abuse You the audience

More Related